Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digene Total in Acid Peptic Disorder
NCT01214408Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Digene Total in acid peptic disorder (APD) (2 arms), sponsored by Abbott Laboratories. Primary endpoint: Time taken to achieve a gastric pH of > 4 after a single dose of Digene Total at Day 1. Started Mar 2011; status: completed.
02
Drugs
Digene Total
03
Conditions
acid peptic disorder (APD)
Beyond the preview
Go deeper on NCT01214408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01214408.